Schering-Plough appointments
This article was originally published in The Tan Sheet
Executive Summary
Appointment of Michael DuBois to head of global licensing announced Sept. 12. DuBois will manage all acquisitions of new products discovered outside of company's labs, and will report to CEO Fred Hassan. DuBois formerly was senior VP - global licensing at Pharmacia. Jeffery Winton also named group VP - global communications, Kenliworth, N.J.-based firm announces Sept. 12. Winton will assume responsibility for both corporate internal and external communications worldwide, and will report to General Counsel Joseph Connors. Winton previously served as VP - global public relations for Pharmacia...
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.